🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
CORONA Remedies Limited (NSE:CORONA)
India flag India · Delayed Price · Currency is INR
2,236.70
-19.50 (-0.86%)
At close: Nov 19, 2026

CORONA Remedies Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
2,0701,8511,494905.03849.29-4
Depreciation & Amortization
477.8376368.6279.84199.04202.82
Other Amortization
2.72.732.941.992.02
Loss (Gain) From Sale of Assets
-5.47.112.050.2-
Loss (Gain) From Sale of Investments
-0.2-0.7-0.2-2.56-2.46-1.01
Loss (Gain) on Equity Investments
-4.4-2.7-3.8-0.06-2.28-
Provision & Write-off of Bad Debts
1.92.30.5-1.322.210.65
Other Operating Activities
106.7119.3206.1278.5128.16-20.02
Change in Accounts Receivable
-93.4-262.1-183.6-126.31-129.171,329
Change in Inventory
-627.452.1-333.964.71-314.54-433.47
Change in Accounts Payable
321.937.1294.2201.1698.28125.56
Change in Other Net Operating Assets
31.9114.252.6-46.41296.28-224.01
Operating Cash Flow
2,2882,2951,9051,5681,027977.05
Operating Cash Flow Growth
14.86%20.47%21.52%52.64%5.11%23.42%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-1,680-1,741-916.6-2,863-947.58-340.07
Sale of Property, Plant & Equipment
8.15.46.45.719.5-
Investment in Securities
-534.8-896.227.5144.61375.88-404.07
Other Investing Activities
90.970.644.146.6559.7586.34
Investing Cash Flow
-2,115-2,562-838.6-2,666-502.45-657.8

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-1,162-288.112.64-
Long-Term Debt Issued
---1,800--
Total Debt Issued
1,1641,162-2,0882.64-
Short-Term Debt Repaid
---204.4---26.85
Long-Term Debt Repaid
--387.8-533.7-788.59-336.64-151.67
Lease Payments
-29.3-27.8-23.7-18.59-19.93-17.14
Total Debt Repaid
-644-387.8-738.1-788.59-336.64-178.52
Net Debt Issued (Repaid)
520.1773.8-738.11,300-334-178.52
Common Dividends Paid
-611.6-447.1-226.3-169.41-69.72-69.94
Other Financing Activities
-83-73.9-101.3-144.66-43.75-50.14
Financing Cash Flow
-174.5252.8-1,066985.45-447.47-298.6

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-0.1--0.02-0.38-0.3
Net Cash Flow
-2.2-13.90.6-113.3876.720.35

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
608.2553.5988.3-1,29679.42636.98
Free Cash Flow Growth
-47.48%-43.99%---87.53%84.55%
Free Cash Flow Margin
3.90%3.94%8.26%-12.77%0.90%10.32%
Free Cash Flow Per Share
9.949.0516.16-21.191.3612.48
Levered Free Cash Flow
66.28-41.991,163-1,796-24.62-221.01
Unlevered Free Cash Flow
117.65-0.111,227-1,709-0.07-192.59
Free Cash Flow After Leases
578.9525.7964.6-1,31459.49619.84

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
8373.9101.3144.6643.7550.14
Cash Income Tax Paid
603.5494.2432.8179.05258.2214.99
Change in Working Capital
-367-58.7-170.793.15-49.15796.59